IsoRay Inc (ISR):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:IsoRay Inc (ISR) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7360
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:36
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
IsoRay Inc (IsoRay), formerly Century Park Pictures Corporation, is a medical technology company which develops, manufactures and markets isotope-based personalized brachytherapy products and devices for the treatment of cancer and other malignant tumors. The company produced Cesium-131, a radioactive isotope used in brachytherapy for the treatment of prostate, brain, lung, head, neck and gynecological cancers. Brachytherapy involves placing the radiation sources – seeds – very close to the tumor site in order to destroy the cancer cells. Cesium 131 provides a specifically targeted, quick-acting radiation treatment. Its initial application is the treatment of localized prostate cancer. It serves medical centers, hospitals and clinics across the US. IsoRay is headquartered in Richland, Washington, the US.

IsoRay Inc (ISR) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
IsoRay Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
IsoRay Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
IsoRay Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
IsoRay Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
IsoRay Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
IsoRay Inc, Medical Equipment, Deal Details 11
Equity Offering 11
IsoRay to Raise USD8.3 Million in Private Placement of Shares 11
IsoRay Completes Private Placement Of Shares For US$14.7 Million 13
IsoRay Amends Terms Of Public Offering Of Units For US$3.7 Million 14
IsoRay Inc – Key Competitors 15
IsoRay Inc – Key Employees 16
IsoRay Inc – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Financial Announcements 18
May 03, 2018: IsoRay Announces Third Quarter Fiscal 2018 Revenue of $1.57 Million, 23% Third Quarter-Over-Third Quarter Increase 18
Apr 18, 2018: IsoRay Announces Preliminary Third Quarter Fiscal 2018 Financial Results 19
Jan 24, 2018: IsoRay Announces Preliminary Second Quarter F2018 Revenue of $1.54 Million, 50% Year-over-Year Increase 20
Nov 14, 2017: IsoRay Announces First Quarter Fiscal 2018 Financial Results 21
Aug 04, 2017: IsoRay Announces Preliminary Fourth Quarter F2017 Revenue of $1.37 Million, 22% Year-over-Year Increase 22
May 10, 2017: IsoRay Announces Third Quarter Fiscal 2017 Financial Results 23
Feb 08, 2017: IsoRay Announces Second Quarter Fiscal 2017 Financial Results 25
Corporate Communications 27
Jun 19, 2018: IsoRay Announces Entry into Employment Agreement with Lori A. Woods as Interim CEO 27
Jun 05, 2018: IsoRay Announces Senior Management Change 28
Jul 07, 2017: Isoray announces appointment of mark austin as controller, principal accounting and financial officer 29
Legal and Regulatory 30
Mar 09, 2017: IsoRay Announces Final Court Approval of Class Action Settlement 30
Government and Public Interest 31
Sep 12, 2018: IsoRay: Three recent peer-reviewed publications reinforce the value of brachytherapy as a treatment for prostate cancer 31
Product News 32
Mar 21, 2018: New study reports that combination treatment with brachytherapy yields significantly better outcomes for men with aggressive prostate cancer 32
Sep 26, 2017: IsoRay Announces Study Accepted for Publication in the International Journal of Radiation Oncology, Biology, Physics entitled “Re-irradiation using Permanent Interstitial Brachytherapy 33
Sep 25, 2017: IsoRay Announces “Long-term PSA Outcomes in a Single Institution, Prospective Randomized Cesium-131 / Iodine-125 Permanent Prostate Brachytherapy Trial” Poster Presentation at 2017 Annual American Society for Radiation Oncology Conference 34
May 03, 2017: IsoRay Announces Study Accepted for Publication in The International Journal of Radiation Oncology, Biology, Physics entitled “Long-term Quality of Life in Prostate Cancer Patients Treated with Cesium-131” 35
Appendix 36
Methodology 36
About GlobalData 36
Contact Us 36
Disclaimer 36

List of Tables
IsoRay Inc, Medical Equipment, Key Facts, 2017 2
IsoRay Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
IsoRay Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
IsoRay Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
IsoRay Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
IsoRay Inc, Deals By Market, 2012 to YTD 2018 9
IsoRay Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
IsoRay to Raise USD8.3 Million in Private Placement of Shares 11
IsoRay Completes Private Placement Of Shares For US$14.7 Million 13
IsoRay Amends Terms Of Public Offering Of Units For US$3.7 Million 14
IsoRay Inc, Key Competitors 15
IsoRay Inc, Key Employees 16
IsoRay Inc, Subsidiaries 17

List of Figures
IsoRay Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
IsoRay Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
IsoRay Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
IsoRay Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
IsoRay Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
IsoRay Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
IsoRay Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[IsoRay Inc (ISR):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • St.George Bank:企業の戦略的SWOT分析
    St.George Bank - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Thornton & Ross Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Thornton & Ross Ltd (Thornton & Ross), a subsidiary of Stada Arzneimittel AG is a supplier of medicines and healthcare products. The company offers over the counter pharmaceutical products. It also manufactures pharmaceutical creams, liquids and semi-solids. Thornton & Ross’ products compris …
  • H2O Retailing Corp:企業の戦略・SWOT・財務分析
    H2O Retailing Corp - Strategy, SWOT and Corporate Finance Report Summary H2O Retailing Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • MGC Diagnostics Corp (MGCD):企業の財務・戦略的SWOT分析
    Summary MGC Diagnostics Corp (MGC Diagnostics) is a medical device company that provides cardio respiratory health solutions. The company provides PFT, metabolic CPET and CPX and indirect calorimetry products. Its PFT products include plethysmograph, pulmonary function systems, spirometry and forced …
  • FieldPoint Petroleum Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q3, 2017
    FieldPoint Petroleum Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2017 Summary FieldPoint Petroleum Corp (FieldPoint) is an oil and gas company that acquires, operates and develops oil and gas properties. The company’s acquisition includes leasehold and working intere …
  • ICF International, Inc.:戦略・SWOT・企業財務分析
    ICF International, Inc. - Strategy, SWOT and Corporate Finance Report Summary ICF International, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Guided Therapeutics Inc (GTHP):企業の財務・戦略的SWOT分析
    Summary Guided Therapeutics Inc (GTI), formerly SpectRx Inc is a biotechnology company that offers platform technology for the early detection of disease that leads to cancer. The company provides products for the non-invasive cervical cancer detection markets. Its products include luviva, a non-inv …
  • QuadraMed Corp:医療機器:M&Aディール及び事業提携情報
    Summary Quadramed Corporation (Quadramed), is a N. Harris Computer Corp., is a healthcare technologies and service provider. It provides solutions to various healthcare organizations to improve the safety, efficiency and quality of patient care. The company's solutions enable its clients in streamli …
  • Samart Corporation Plc (SAMART):企業の財務・戦略的SWOT分析
    Samart Corporation Plc (SAMART) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Sumitomo Electric Industries Ltd (5802):企業の財務・戦略的SWOT分析
    Sumitomo Electric Industries Ltd (5802) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Corcept Therapeutics Inc (CORT):製薬・医療:M&Aディール及び事業提携情報
    Summary Corcept Therapeutics Inc (Corcept) is a research focused pharmaceutical company which discovers, develops and commercializes innovative therapeutics in the areas of psychiatric and metabolic diseases. The company focuses on developing drugs for the treatment of severe metabolic, oncologic an …
  • Hays plc:企業の戦略・SWOT・財務情報
    Hays plc - Strategy, SWOT and Corporate Finance Report Summary Hays plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • SFS Group AG:企業の戦略・SWOT・財務分析
    SFS Group AG - Strategy, SWOT and Corporate Finance Report Summary SFS Group AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Monsanto Company (MON)-製薬・医療分野:企業M&A・提携分析
    Summary Monsanto Company (Monsanto) is an agricultural products manufacturing company. It develops and delivers agricultural products to support farmers all around the world. The company develops biotechnology traits that assist farmers in controlling insects and weeds. Monsanto also provides other …
  • Milliken & Company:戦略・SWOT・企業財務分析
    Milliken & Company - Strategy, SWOT and Corporate Finance Report Summary Milliken & Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Celdara Medical LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Celdara Medical LLC (Celdara Medical) is a biotechnology company that helps transform academic innovations into medicines to cure serious diseases. It provides pipeline development services, and has a pipeline of anti-inflammatory therapeutics, latent HIV elimination, idiopathic pulmonary fi …
  • Sun Pharma Advanced Research Company Ltd (SPARC):企業の財務・戦略的SWOT分析
    Summary Sun Pharma Advanced Research Company Ltd (SPARC), a subsidiary of Sun Pharmaceutical Industries Ltd, is a bio pharmaceutical clinical research and development service provider. The company develops active pharmaceutical ingredients, formulations and drug delivery technologies for the treatme …
  • Shearman & Sterling LLP:企業の戦略的SWOT分析
    Shearman & Sterling LLP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • United Microelectronics Corporation (2303):企業の財務・戦略的SWOT分析
    United Microelectronics Corporation (2303) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • I-O Data Device, Inc. (6916):企業の財務・戦略的SWOT分析
    I-O Data Device, Inc. (6916) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆